New England Capital Financial Advisors LLC Bristol Myers Squibb CO Transaction History
New England Capital Financial Advisors LLC
- $205 Billion
- Q4 2024
A detailed history of New England Capital Financial Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, New England Capital Financial Advisors LLC holds 6,376 shares of BMY stock, worth $356,864. This represents 0.18% of its overall portfolio holdings.
Number of Shares
6,376
Previous 6,365
0.17%
Holding current value
$356,864
Previous $329 Million
9.51%
% of portfolio
0.18%
Previous 0.17%
Shares
9 transactions
Others Institutions Holding BMY
# of Institutions
2,706Shares Held
1.54BCall Options Held
32MPut Options Held
34.2M-
Vanguard Group Inc Valley Forge, PA190MShares$10.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.88 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.37 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.33 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.38 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...